Navigation Links
Matuzumab in Medical News

Merck and Takeda to collaborate in the sale of Cancer drug Matuzumab

Merck Pharmaceuticals from Germany and Takeda Pharmaceuticals from Japan to colloborate in marketing of Merck's cancer drug Matuzumab. Matuzumab is developed by Merck which is in its Phase II // clinical tiral. Takeda Pharmaceuticals will sign agreement with Merck to give royalty and sale be...

Double binding sites on tumor target may provide future combination therapy

...r other types of cancer. An additional drug called matuzumab is in phase II clinical trials. Three years ago...s found again using X-ray crystallography -- that matuzumab binds in a different place from Erbitux. Their bin...has important implications for the clinical use of matuzumab and for developing new therapies that target EGFR....
Matuzumab in Medical Technology

ImClone Systems Showcases Extensive Research and Development Program at the AACR Annual Meeting

...fferent anti-EGFR agents, including other monoclonal antibodies, have different biological effects. (#336 Meira et al. Differences in activity between matuzumab and cetuximab in A431 cells may rely on MAPK cascade inhibition.) -- Emerging biomarkers may serve as predictors of clinical response to ERBITUX. (#...
Matuzumab in other areas

Matuzumab - Wikipedia, the free encyclopedia

Matuzumab is a humanized monoclonal antibody for the treatment of cancer. It binds to EGFR with high affinity.

Matuzumab (EMD72000)

... please contact the site administrator at: matuzumab@emdpharmaceuticals.com. Matuzumab is currently under clinical investigation and has not been approved ...

Definition of matuzumab - National Cancer Institute Drug Dictionary

matuzumab. A humanized monoclonal antibody with antineoplastic activity. Matuzumab binds the epidermal growth factor receptor (EGFR) with high affinity, ...

Definition of matuzumab - NCI Dictionary of Cancer Terms

matuzumab. A monoclonal antibody that is being studied in the treatment of ... Matuzumab binds to the epithelial growth factor receptor (EGFR) on tumor cells ...

Matuzumab facts - Freebase

Facts and figures about Matuzumab, taken from Freebase, the world's database. ... If you know more about Matuzumab, you can add more facts here " ...

Merck KGaA 'reconsidering' further development of Matuzumab in ...

FRANKFURT (Thomson Financial) - Merck KGaA said its division Merck Serono's Phase II trial of Matuzumab to treat metastatic colorectal cancer (mCRC) did not meet its ...
Other Tags
(Date:4/21/2015)... 2015 According to a recent article ... Gov. Wolf has made naloxone available for anyone to ... from a pharmacy without a doctor’s order- in an ... drug addiction. Pennsylvania’s state police will also begin carrying ... in Narcan) is an opiate overdose reversal medication. The ...
(Date:4/21/2015)... Lake City, Utah (PRWEB) April 21, 2015 ... reimbursement for small businesses, announced today the publication of ... , Recent health reform brought changes to the health ... changes caused some business owners to question what is ... use eBook helps small business owners determine which HRAs ...
(Date:4/21/2015)... Carinsuranceshoppingsource.com has released a new blog ... for ecological vehicles. , Eco-friendly cars can ... safer driving experience. Some insurance agencies may even offer ... a new vehicle, clients should consider the costs of ... car will always cost more to insure. Eco-friendly vehicles ...
(Date:4/21/2015)... Quark Software Inc. has introduced ... solution that enables large enterprises to streamline the ... With Quark Procedure Management, corporate writers and subject ... to save, search and update, which is critical ... issues. Examples of policies and procedures include employee ...
(Date:4/21/2015)... A new study at a British hospital shows ... like mesothelioma increased by 20 percent over a 20 ... of the study. Click here to read the ... Hospital in Basingstoke performed a retrospective analysis of outcomes ... between 1994 and 2014. They found that patients ...
Breaking Medicine News(10 mins):Health News:Drug Rehab Philadelphia Comments on Gov. Wolf’s Decision to Make Naloxone Widely Available 2Health News:Auto Insurance Quotes For Eco-Friendly Vehicles 2Health News:Quark Software Inc. Introduces Procedure Management Solution for Global 2000 2Health News:Quark Software Inc. Introduces Procedure Management Solution for Global 2000 3Health News:New Findings Highlight Value of Experience in Peritoneal Mesothelioma Treatment, According to Surviving Mesothelioma 2
(Date:4/9/2015)... Calif. , April 9, 2015 Synaptics ... interface solutions, announced today that it will report financial ... Thursday, April 23, 2015, after the close of market. ... analysts and investors at 2:00 p.m. PT (5:00 p.m. ... To participate on the live call, analysts ...
(Date:4/2/2015)... According to preliminary estimates Fingerprint ... higher than 125 MSEK. This exceeds the guidance provided ... revenues for Q1 2015 would be in line with ... 2014. The operating result for the first quarter is ... report will as previously communicated be published on May ...
(Date:3/31/2015)...   Guidepoint , a leading global research services ... Management TRACKER, part of the Guidepoint TRACKER ... medical device and therapeutics markets. The Post-Surgical Pain Management ... market share, and adoption rates across three major modalities ... The Post-Surgical Pain Management TRACKER will provide ...
Breaking Biology News(10 mins):Synaptics to Report Third Quarter Results on April 23 2Fingerprint Cards Revises Revenues for Q1 2015 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3
Other Contents